Effects of MSC coadministration and route of delivery on cord blood hematopoietic stem cell engraftment

Cell Transplantation

Volumn 22, Issue 7, 2013, Pages 1171-1183

  Carrancio, S ^a,b,c   Romo, C ^a,b,c   Ramos, T ^b,c   Lopez Holgado, N ^b,c   Muntion, S ^b,c   Prins, H J ^d   Martens, A C ^d   Brinon J G ^e   San Migue, J F ^a,b,c   del Canizo M C ^a,b,c   Sanchez Guijo, F ^a,b,c  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b ISCIII)   (Spain)

^c CSIC   (Spain)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bone marrow microenvironment; Cordon blood transplantation; Hematopoietic engraftment; Mesenchymal stem cells (MSCs)

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CD19 ANTIGEN; CD34 ANTIGEN; ENDOGLIN; HERMES ANTIGEN; MICROSOMAL AMINOPEPTIDASE; THY 1 ANTIGEN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; BLOOD VESSEL; CELL COUNT; CHIMERA; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; FEMUR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; STEM CELL NICHE; UMBILICAL CORD BLOOD;

ADULT; ANIMALS; ANTIGENS, CD34; ANTIGENS, CD45; B-LYMPHOCYTES; BONE AND BONES; BONE MARROW CELLS; CHIMERISM; FEMALE; FETAL BLOOD; GRAFT SURVIVAL; HEK293 CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 84879560059     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368912X657431     Document Type: Article

References (57)

1. Bartsch, K.; Al-Ali, H.; Reinhardt, A.; Franke, C.; Hudecek, M.; Kamprad, M.; Tschiedel, S.; Cross, M.; Niederwieser, D.; Gentilini, C. Mesenchymal stem cells remain hostderived independent of the source of the stem-cell graft and conditioning regimen used. Transplantation 87:217-221; 2009
2. Bianco, P. Bone and the hematopoietic niche: A tale of two stem cells. Blood 117:5281-5288; 2011
3. Bueno, C.; Montes, R.; de la Cueva, T.; Gutierrez-Aranda, I.; Menendez, P. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation. Cytotherapy 12:45-49; 2010
4. Carlotti, F.; Bazuine, M.; Kekarainen, T.; Seppen, J.; Pognonec, P.; Maassen, J. A.; Hoeben, R. C. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 9:209-217; 2004
5. Carrancio, S.; Lopez-Holgado, N.; Sanchez-Guijo, F. M.; Villaron, E.; Barbado, V.; Tabera, S.; Diez-Campelo, M.; Blanco, J.; San Miguel, J. F.; Del Canizo, M. C. Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp. Hematol. 36:1014-1021; 2008
6. Castello, S.; Podesta, M.; Menditto, V. G.; Ibatici, A.; Pitto, A.; Figari, O.; Scarpati, D.; Magrassi, L.; Bacigalupo, A.; Piaggio, G.; Frassoni, F. Intra-bone marrow injection of bone marrow and cord blood cells: An alternative way of transplantation associated with a higher seeding efficiency. Exp. Hematol. 32:782-787; 2004
7. Chen, Y. T.; Sun, C. K.; Lin, Y. C.; Chang, L. T.; Chen, Y. L.; Tsai, T. H.; Chung, S. Y.; Chua, S.; Kao, Y. H.; Yen, C. H.; Shao, P. L.; Chang, K. C.; Leu, S.; Yip, H. K. Adipose-derived mesenchymal stem cell protects kidneys against ischemiareperfusion injury through suppressing oxidative stress and inflammatory reaction. J. Transl. Med. 9:51; 2011
8. Del Canizo, M. C.; Fernandez, M. E.; Lopez, A.; Vidriales, B.; Villaron, E.; Arroyo, J. L.; Ortuno, F.; Orfao, A.; San Miguel, J. F. Immunophenotypic analysis of myelodysplastic syndromes. Haematologica 88:402-407; 2003
9. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317; 2006
10. Fernandez, M. N. Improving the outcome of cord blood transplantation: Use of mobilized HSC and other cells from third party donors. Br. J. Haematol. 147:161-176; 2009
11. Follenzi, A.; Ailles, L. E.; Bakovic, S.; Geuna, M.; Naldini, L. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25:217-222; 2000
12. Follenzi, A.; Naldini, L. HIV-based vectors. Preparation and use. Methods Mol. Med. 69:259-274; 2002
13. Frassoni, F.; Gualandi, F.; Podesta, M.; Raiola, A. M.; Ibatici, A.; Piaggio, G.; Sessarego, M.; Sessarego, N.; Gobbi, M.; Sacchi, N.; Labopin, M.; Bacigalupo, A. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: A phase I/II study. Lancet Oncol. 9:831-839; 2008
14. Garrett, R. W.; Emerson, S. G. Bone and blood vessels: The hard and the soft of hematopoietic stem cell niches. Cell Stem Cell 4:503-506; 2009
15. Geuze, R. E.; Prins, H. J.; Oner, F. C.; van der Helm, Y. J.; Schuijff, L. S.; Martens, A. C.; Kruyt, M. C.; Alblas, J.; Dhert, W. J. Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Tissue Eng. Part A 16:3343-3351; 2010
16. Gluckman, E.; Ruggeri, A.; Volt, F.; Cunha, R.; Boudjedir, K.; Rocha, V. Milestones in umbilical cord blood transplantation. Br. J. Haematol. 154:441-447; 2011
17. Gonzalo-Daganzo, R.; Regidor, C.; Martin-Donaire, T.; Rico, M. A.; Bautista G.; Krsnik, I.; Fores, R.; Ojeda, E.; Sanjuan, I.; Garcia-Marco, J. A.; Navarro, B.; Gil, S.; Sanchez, R.; Panadero, N.; Gutierrez, Y.; Garcia-Berciano, M.; Perez, N.; Millan, I.; Cabrera, R.; Fernandez, M. N. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults. Cytotherapy 11:278-288; 2009
18. Guo, C. J.; Gao, Y.; Hou, D.; Shi, D. Y.; Tong, X. M.; Shen, D.; Xi, Y. M.; Wang, J. F. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood. World J. Stem Cells 3:43-52; 2011
19. Herr, A. L.; Kabbara, N.; Bonfim, C. M.; Teira, P.; Locatelli, F.; Tiedemann, K.; Lankester, A.; Jouet, J. P.; Messina, C.; Bertrand, Y.; Diaz de Heredia, C.; Peters, C.; Chaves, W.; Nabhan, S. K.; Ionescu, I.; Gluckman, E.; Rocha, V. Longterm follow-up and factors influencing outcomes after related HLA-identical cord blood transplantation for patients with malignancies: An analysis on behalf of Eurocord-EBMT. Blood 116:1849-1856; 2010
20. Hesselton, R. M.; Greiner, D. L.; Mordes, J. P.; Rajan, T. V.; Sullivan, J. L.; Shultz, L. D. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type 1 infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172:974-982; 1995
21. Hiwase, S. D.; Dyson, P. G.; To, L. B.; Lewis, I. D. Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice. Stem Cells 27:2293-2300; 2009
22. Ikehara, S. Intra-bone marrow-bone marrow transplantation: A new strategy for treatment of stem cell disorders. Ann. N.Y. Acad. Sci. 1051:626-634; 2005
23. Jang, K. S.; Lee, K. S.; Yang, S. H.; Jeun, S. S. In vivo tracking of transplanted bone marrow-derived mesenchymal stem cells in a murine model of stroke by bioluminescence imaging. J. Korean Neurosurg. Soc. 48:391-398; 2010
24. Kanathezhath, B.; Walters, M. C. Umbilical cord blood transplantation for thalassemia major. Hematol. Oncol. Clin. North. Am. 24:1165-1177; 2010
25. Kanda, J.; Rizzieri, D. A.; Gasparetto, C.; Long, G. D.; Chute, J. P.; Sullivan, K. M.; Morris, A.; Smith, C. A.; Hogge, D. E.; Nitta, J.; Song, K.; Niedzwiecki, D.; Chao, N. J.; Horwitz, M. E. Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning. Biol. Blood Marrow Transplant. 17:867-874; 2011
26. Karp, J. M.; Leng Teo, G. S. Mesenchymal stem cell homing: The devil is in the details. Cell Stem Cell 4:206-216; 2009
27. Le Blanc, K.; Gotherstrom, C.; Ringden, O.; Hassan, M.; McMahon, R.; Horwitz, E.; Anneren, G.; Axelsson, O.; Nunn, J.; Ewald, U.; Norden-Lindeberg, S.; Jansson, M.; Dalton, A.; Astrom, E.; Westgren, M. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614; 2005
28. Li, X.; Ling, W.; Pennisi, A.; Wang, Y.; Khan, S.; Heidaran, M.; Pal, A.; Zhang, X.; He, S.; Zeitlin, A.; Abbot, S.; Faleck, H.; Hariri, R.; Shaughnessy, Jr., J. D.; van Rhee, F.; Nair, B.; Barlogie, B.; Epstein, J.; Yaccoby, S. Human placentaderived adherent cells prevent bone loss, stimulate bone formation, and suppress growth of multiple myeloma in bone. Stem Cells 29:263-273; 2011
29. Lozito, T. P.; Kuo, C. K.; Taboas, J. M.; Tuan, R. S. Human mesenchymal stem cells express vascular cell phenotypes upon interaction with endothelial cell matrix. J. Cell. Biochem. 107:714-722; 2009
30. Macmillan, M. L.; Blazar, B. R.; DeFor, T. E.; Wagner, J. E. Transplantation of ex-vivo culture-expanded parental haploidentical mesenchymal stem cells to promote engraftment in pediatric recipients of unrelated donor umbilical cord blood: Results of a phase I-II clinical trial. Bone Marrow Transplant. 43:447-454; 2009
31. Madureira, A. B.; Eapen, M.; Locatelli, F.; Teira, P.; Zhang, M. J.; Davies, S. M.; Picardi, A.; Woolfrey, A.; Chan, K. W.; Socie, G.; Vora, A.; Bertrand, Y.; Sales-Bonfim, C. M.; Gluckman, E.; Niemeyer, C.; Rocha, V. Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation. Leukemia 25:449-454; 2011
32. Majhail, N. S.; Brunstein, C. G.; Shanley, R.; Sandhu, K.; McClune, B.; Oran, B.; Warlick, E. D.; Wagner, J. E.; Weisdorf, D. J. Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: Umbilical cord blood is a feasible option for patients without HLAmatched sibling donors. Bone Marrow Transplant. 47:494-498; 2012
33. Marigo, I.; Dazzi, F. The immunomodulatory properties of mesenchymal stem cells. Semin. Immunopathol. 33:593-602; 2011
34. Massollo, M.; Podesta, M.; Marini, C.; Morbelli, S.; Cassanelli, C.; Pinto, V.; Ubezio, G.; Curti, G.; Uccelli, A.; Frassoni, F.; Sambuceti, G. Contact with the bone marrow microenvironment readdresses the fate of transplanted hematopoietic stem cells. Exp. Hematol. 38:968-977; 2010
35. Mazurier, F.; Doedens, M.; Gan, O. I.; Dick, J. E. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat. Med. 9:959-963; 2003
36. Mendez-Ferrer, S.; Michurina, T. V.; Ferraro, F.; Mazloom, A. R.; Macarthur, B. D.; Lira, S. A.; Scadden, D. T.; Ma'ayan, A.; Enikolopov, G. N.; Frenette, P. S. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466:829-834; 2010
37. Meuleman, N.; Tondreau, T.; Ahmad, I.; Kwan, J.; Crokaert, F.; Delforge, A.; Dorval, C.; Martiat, P.; Lewalle, P.; Lagneaux, L.; Bron, D. Infusion of mesenchymal stromal cells can aid hematopoietic recovery following allogeneic hematopoietic stem cell myeloablative transplant: A pilot study. Stem Cells Dev. 18:1247-1252; 2009
38. Mohty, M.; Ho, A. D. In and out of the niche: Perspectives in mobilization of hematopoietic stem cells. Exp. Hematol. 39:723-729; 2011
39. Nakamura, Y.; Arai, F.; Iwasaki, H.; Hosokawa, K.; Kobayashi, I.; Gomei, Y.; Matsumoto, Y.; Yoshihara, H.; Suda, T. Isolation and characterization of endosteal niche cell populations that regulate hematopoietic stem cells. Blood 116:1422-1432; 2010
40. Noort, W. A.; Kruisselbrink, A. B.; In't Anker, P. S.; Kruger, M.; van Bezooijen, R. L.; de Paus, R. A.; Heemskerk, M. H.; Lowik, C. W.; Falkenburg, J. H.; Willemze, R.; Fibbe, W. E. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp. Hematol. 30:870-878; 2002
41. Oran, B.; Wagner, J. E.; DeFor, T. E.; Weisdorf, D. J.; Brunstein, C. G. Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantation. Biol. Blood Marrow Transplant. 17:1327-1334; 2011
42. Petropoulou, A. D.; Rocha, V. Risk factors and options to improve engraftment in unrelated cord blood transplantation. Stem Cells Int. 2011:610514; 2011
43. Pozzi, S.; Lisini, D.; Podesta, M.; Bernardo, M. E.; Sessarego, N.; Piaggio, G.; Cometa, A.; Giorgiani, G.; Mina, T.; Buldini, B.; Maccario, R.; Frassoni, F.; Locatelli, F. Donor multipotent mesenchymal stromal cells may engraft in pediatric patients given either cord blood or bone marrow transplantation. Exp. Hematol. 34:934-942; 2006
44. Ramirez, P. A.; Wagner, J. E.; Brunstein, C. G. Going straight to the point: Intra-BM injection of hematopoietic progenitors. Bone Marrow Transplant. 45:1127-1133; 2010
45. Rocha, V.; Crotta, A.; Ruggeri, A.; Purtill, D.; Boudjedir, K.; Herr, A. L.; Ionescu, I.; Gluckman, E. Double cord blood transplantation: Extending the use of unrelated umbilical cord blood cells for patients with hematological diseases. Best Pract. Res. Clin. Haematol. 23:223-229; 2010
46. Sanchez-Guijo, F. M.; Blanco, J. F.; Cruz, G.; Muntion, S.; Gomez, M.; Carrancio, S.; Lopez-Villar, O.; Barbado, M. V.; Sanchez-Abarca, L. I.; Blanco, B.; Brinon, J. G.; del Canizo, M. C. Multiparametric comparison of mesenchymal stromal cells obtained from trabecular bone by using a novel isolation method with those obtained by iliac crest aspiration from the same subjects. Cell Tissue Res. 336:501-507; 2009
47. Tabera, S.; Perez-Simon, J. A.; Diez-Campelo, M.; Sanchez- Abarca, L. I.; Blanco, B.; Lopez, A.; Benito, A.; Ocio, E.; Sanchez-Guijo, F. M.; Canizo, C.; San Miguel, J. F. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93:1301-1309; 2008
48. Tark, K. C.; Hong, J. W.; Kim, Y. S.; Hahn, S. B.; Lee, W. J.; Lew, D. H. Effects of human cord blood mesenchymal stem cells on cutaneous wound healing in leprdb mice. Ann. Plast. Surg. 65:565-572; 2010
49. Trouche, E.; Girod, F. S.; Mias, C.; Ceccaldi, C.; Tortosa, F.; Seguelas, M. H.; Calise, D.; Parini, A.; Cussac, D.; Sallerin, B. Evaluation of alginate microspheres for mesenchymal stem cell engraftment on solid organ. Cell Transplant. 19: 1623-1633; 2010
50. Tung, S. S.; Parmar, S.; Robinson, S. N.; de Lima, M.; Shpall, E. J. Ex vivo expansion of umbilical cord blood for transplantation. Best Pract. Res. Clin. Haematol. 23:245-257; 2010
51. van Velthoven, C. T.; Kavelaars, A.; van Bel, F.; Heijnen, C. J. Nasal administration of stem cells: A promising novel route to treat neonatal ischemic brain damage. Pediatr. Res. 68:419-422; 2010
52. Verlinden, S. F.; van Es, H. H.; van Bekkum, D. W. Serial bone marrow sampling for long-term follow up of human hematopoiesis in NOD/SCID mice. Exp. Hematol. 26:627-630; 1998
53. Villaron, E. M.; Almeida, J.; Lopez-Holgado, N.; Alcoceba, M.; Sanchez-Abarca, L. I.; Sanchez-Guijo, F. M.; Alberca, M.; Perez-Simon, J. A.; San Miguel, J. F.; Del Canizo, M. C. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 89:1421-1427; 2004
54. Wang, W.; Jiang, Q.; Zhang, H.; Jin, P.; Yuan, X.; Wei, Y.; Hu, S. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen. Med. 6:179-190; 2011
55. Yahata, T.; Ando, K.; Sato, T.; Miyatake, H.; Nakamura, Y.; Muguruma, Y.; Kato, S.; Hotta, T. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101:2905-2913; 2003
56. Zhong, X. Y.; Zhang, B.; Asadollahi, R.; Low, S. H.; Holzgreve, W. Umbilical cord blood stem cells: What to expect. Ann. N.Y. Acad. Sci. 1205:17-22; 2010
57. Zhu, H.; Song, X.; Jin, L. J.; Jin, P.; Guan, R.; Liu, X.; Li, X. Q. Comparison of intra-coronary cell transplantation after myocardial infarction: Autologous skeletal myoblasts versus bone marrow mesenchymal stem cells. J. Int. Med. Res. 37:298-307; 2009.